153 related articles for article (PubMed ID: 31655393)
1. The role of a low erythropoietin level in the diagnosis of JAK2 exon 12-mutated polycythemia vera.
Langabeer SE
Blood Cells Mol Dis; 2020 Feb; 80():102377. PubMed ID: 31655393
[No Abstract] [Full Text] [Related]
2. Somatic mutations of JAK2 exon 12 as a molecular basis of erythrocytosis.
Cazzola M
Haematologica; 2007 Dec; 92(12):1585-9. PubMed ID: 18055979
[No Abstract] [Full Text] [Related]
3. Revisiting Diagnostic performances of serum erythropoïetin level and JAK2 mutation for polycythemias: analysis of a cohort of 1090 patients with red cell mass measurement.
Maslah N; Ravdan O; Drevon L; Verger E; Belkhodja C; Chomienne C; Cassinat B; Kiladjian JJ; Giraudier S; Schlageter MH
Br J Haematol; 2022 Feb; 196(3):676-680. PubMed ID: 34562020
[TBL] [Abstract][Full Text] [Related]
4. The frequency of JAK2 exon 12 mutations in idiopathic erythrocytosis patients with low serum erythropoietin levels.
Percy MJ; Scott LM; Erber WN; Harrison CN; Reilly JT; Jones FG; Green AR; McMullin MF
Haematologica; 2007 Dec; 92(12):1607-14. PubMed ID: 18055983
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Performance of Erythropoietin Levels in Polycythemia Vera: Experience at a Comprehensive Cancer Center.
Davila-Gonzalez D; Barrios-Ruiz A; Fountain E; Cheng L; Masarova L; Verstovsek S; Rojas-Hernandez CM
Clin Lymphoma Myeloma Leuk; 2021 Apr; 21(4):224-229. PubMed ID: 33349602
[TBL] [Abstract][Full Text] [Related]
6. The role of serum erythropoietin level and JAK2 V617F allele burden in the diagnosis of polycythaemia vera.
Ancochea A; Alvarez-Larrán A; Morales-Indiano C; García-Pallarols F; Martínez-Avilés L; Angona A; Senín A; Bellosillo B; Besses C
Br J Haematol; 2014 Nov; 167(3):411-7. PubMed ID: 25040297
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of serum erythropoietin values as defined by 2016 World Health Organization criteria for the diagnosis of polycythemia vera.
Silver RT; Krichevsky S; Gjoni S; Cross NCP
Leuk Lymphoma; 2017 Nov; 58(11):2768-2769. PubMed ID: 28317411
[No Abstract] [Full Text] [Related]
8. The role of a low erythropoietin level for the polycythemia vera diagnosis.
Lupak O; Han X; Xie P; Mahmood S; Mohammed H; Donthireddy V
Blood Cells Mol Dis; 2020 Feb; 80():102355. PubMed ID: 31525610
[TBL] [Abstract][Full Text] [Related]
9. [Polycythemia vera].
Gemünden C; Gerber B
Praxis (Bern 1994); 2012 May; 101(10):631-9, 641; quiz 640. PubMed ID: 22565553
[No Abstract] [Full Text] [Related]
10. Evaluation of "increased" hemoglobin in the JAK2 mutations era: a diagnostic algorithm based on genetic tests.
Tefferi A; Pardanani A
Mayo Clin Proc; 2007 May; 82(5):599-604. PubMed ID: 17493421
[TBL] [Abstract][Full Text] [Related]
11. A refined diagnostic algorithm for polycythemia vera that incorporates mutation screening for JAK2(V617F).
Tefferi A
Curr Hematol Malig Rep; 2006 Jun; 1(2):81-6. PubMed ID: 20425336
[TBL] [Abstract][Full Text] [Related]
12. Apparent 'JAK2-negative' polycythaemia vera due to compound mutations in exon 14.
Tiong IS; Casolari DA; Moore S; Nguyen T; Van Velzen MJM; Zantomio D; Scott HS; D'Andrea RJ; Hahn CN; Ross DM
Br J Haematol; 2017 Jul; 178(2):333-336. PubMed ID: 27136492
[No Abstract] [Full Text] [Related]
13. Resolution of thrombocytopenia, but not polycythemia after ruxolitinib for polycythemia vera with detectable mutation in the exon 12 of the JAK2 gene.
Helbig G; Wichary R; Torba K; Kyrcz-Krzemień S
Med Oncol; 2017 Mar; 34(3):31. PubMed ID: 28120162
[No Abstract] [Full Text] [Related]
14. [High hemoglobin, not always polycythaemia vera. Weak evidence for the effect of venesection in other erythrocytoses].
Hultcrantz M; Admasie J; Beshara S; Landin B; Palmblad J
Lakartidningen; 2012 Dec 19-2013 Jan 8; 109(51-52):2354-7. PubMed ID: 23367550
[No Abstract] [Full Text] [Related]
15. Bone marrow morphologic features in polycythemia vera with JAK2 exon 12 mutations.
Lakey MA; Pardanani A; Hoyer JD; Nguyen PL; Lasho TL; Tefferi A; Hanson CA
Am J Clin Pathol; 2010 Jun; 133(6):942-8. PubMed ID: 20472853
[TBL] [Abstract][Full Text] [Related]
16. JAK2V617F detection and dosage of serum erythropoietin: first steps of the diagnostic work-up for patients consulting for elevated hematocrit.
Girodon F; Lippert E; Mossuz P; Dobo I; Boiret-Dupré N; Lesesve JF; Hermouet S; Praloran V
Haematologica; 2007 Mar; 92(3):431-2. PubMed ID: 17339201
[TBL] [Abstract][Full Text] [Related]
17. The JAK2 exon 12 mutations: a comprehensive review.
Scott LM
Am J Hematol; 2011 Aug; 86(8):668-76. PubMed ID: 21674578
[TBL] [Abstract][Full Text] [Related]
18. Diagnosing or ruling out polycythemia vera in patients with erythrocytosis.
Prchal JT
Clin Adv Hematol Oncol; 2019 Jan; 17(1):24-27. PubMed ID: 30843892
[No Abstract] [Full Text] [Related]
19. [Polycytaemia vera].
Ugo V
Rev Prat; 2009 Nov; 59(9):1285-6. PubMed ID: 19961090
[No Abstract] [Full Text] [Related]
20. JAK2 exon 12 mutation in JAK2V617F-negative polycythemia vera.
Röthlisberger B; Huber A; Bargetzi M; Mendez A; Heizmann M
Leuk Lymphoma; 2008 Mar; 49(3):586-8. PubMed ID: 18297539
[No Abstract] [Full Text] [Related]
[Next] [New Search]